
# Title 21— FOOD AND DRUGS
### CHAPTER 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT
#### § 355–1. Risk evaluation and mitigation strategies
##### (l) Provision of samples not a violation of strategy

The provision of samples of a covered product to an eligible product developer (as those terms are defined in section 355–2(a) of this title ) shall not be considered a violation of the requirements of any risk evaluation and mitigation strategy that may be in place under this section for such drug.
